IVONNE ESPINOSA: Open Payments
NPI 1194151217 · EL PASO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$603 in 26 payments from 7 companies in 2025. Trend: 2023 $221 · 2024 $520 · 2025 $603
Food & beverage: $603
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 7 | $198 |
| Vanda Pharmaceuticals Inc. | 8 | $179 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $81 |
| ABBVIE INC. | 3 | $61 |
| Alkermes, Inc. | 2 | $43 |
| Neurocrine BioSciences, Inc. | 1 | $23 |
| Axsome Therapeutics, Inc. | 1 | $18 |
Products named: Qelbree, FANAPT, CAPLYTA, VRAYLAR, ARISTADA, INGREZZA, Auvelity.
Industry payments across TX — which companies pay providers there.
